4 Leukemia Clinical Trials in Norwalk, CT (2026)

Q: How do I join a clinical trial in Norwalk?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Norwalk research site will contact you.

Recruiting Leukemia Studies in Norwalk

NCT01804686Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolle...

Norwalk, CTPHASE3700 participantsJanssen Research & Development, LLC

View Study Details

NCT05671510Recruiting

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who h...

Norwalk, CTPHASE3630 participantsOncoC4, Inc.

View Study Details

NCT06343402Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

A first in human study to evaluate the safety and preliminary antitumor activity of BBO-8520, a KRAS G12C (ON and OFF) inhibitor, as a single agent and in combination with pembrolizumab and BBO-10203 ...

Norwalk, CTPHASE1350 participantsTheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

View Study Details

NCT02926690Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

The purpose of this study is to determine the maximum tolerated dose (MTD) of OTS167 administered via oral capsule (PO) to patients with relapsed/refractory locally advanced or metastatic breast cance...

Norwalk, CTPHASE170 participantsOncoTherapy Science, Inc.

View Study Details

About Leukemia Clinical Trials in Norwalk

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Norwalk, CT. These studies are seeking a combined 1,750 participants. Research is being sponsored by Janssen Research & Development, LLC, OncoC4, Inc., TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Norwalk — FAQ

Are there leukemia clinical trials in Norwalk?

Yes, there are 4 leukemia clinical trials currently recruiting in Norwalk, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Norwalk?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Norwalk research site will contact you about next steps.

Are clinical trials in Norwalk free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Norwalk studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Norwalk are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 21, 2026 from ClinicalTrials.gov